Two researchers from the University of Newcastle, Dr. Geshani Jayasuriya and Dr. Heather Murray, have been awarded $100,000 fellowships for their groundbreaking work in medical innovation. Their projects focus on developing safer and more effective medical treatments, which could significantly impact patient care and outcomes.
Dr. Jayasuriya, a paediatric respiratory physician, is leading the charge in creating radiation-free lung scans using advanced MRI techniques. She highlights the dangers of current CT scan methods, which carry radiation risks, especially for children who require multiple scans. By utilizing MRI, which provides detailed images without radiation, Dr. Jayasuriya aims to revolutionize lung imaging, offering a safer and more comprehensive approach to diagnosing and treating respiratory conditions.
Her work has the potential to transform the way we approach lung health, particularly for patients with cystic fibrosis and asthma. MRI's ability to reveal information about air and blood flow through the lungs, along with its detailed imaging capabilities, will enable more accurate and personalized treatment plans. Dr. Jayasuriya's goal is to bring these advanced MRI techniques to clinical care, starting in the Hunter region and expanding nationwide.
On the other hand, Dr. Murray, a blood cancer researcher, is working on a project to personalize treatment decisions for patients with acute myeloid leukaemia (AML). AML is a highly aggressive form of blood cancer, and current treatment choices are limited to the patient's age and ability to endure intensive chemotherapy. Dr. Murray's innovative platform aims to predict the most effective treatment for each patient, potentially improving survival rates and quality of life.
These fellowships are part of a larger initiative, the Innovator Program, which supports early- and mid-career researchers from the University of Newcastle, Hunter New England Health, and HMRI. The program encourages collaboration with affected individuals to develop practical solutions to healthcare challenges. This year's projects also included infant respiratory risk, wound care, and genomics analysis, with four additional finalists receiving $20,000 seed grants.
The Innovator Program, as described by HMRI director Frances Kay, showcases the value of investing in innovative ideas with the potential to improve lives. Dr. Jayasuriya and Dr. Murray's work exemplifies this, as their projects have the potential to revolutionize diagnostic and treatment methods, ultimately benefiting patients and advancing medical science.
In my opinion, these fellowships are a testament to the power of research and innovation in healthcare. Dr. Jayasuriya and Dr. Murray's dedication to developing safer and more effective treatments is a beacon of hope for patients and a reminder of the importance of investing in medical research. Their work not only has the potential to improve individual lives but also contributes to a broader understanding of medical challenges and solutions.
